Bottom line
What is PACWX's expense ratio?
PACWX's expense ratio is 1.55%, or about $155 a year on every $10,000 invested. That is more expensive than 99% of target-date funds we track (median 0.59%). This share class also charges a front-end sales load of up to 1%, taken from your investment when you buy. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Dec 23, 2025
PACWX fee table
| Net expense ratio | 1.55% |
|---|---|
| Gross expense ratio | 2.94% |
| Management fee | 0.42% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.92% |
| Acquired fund fees | 0.6% |
| Fee waiver / reimbursement | -1.39% |
| Max front-end sales load | 1% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What PACWX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PACWX | $258 | $490 | $1,155 | $2,757 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.55% expense ratio costs roughly $81,800 in lost growth, versus about $33,900 for the median target-date fund (0.59%).